Proposed Data Collections Submitted for Public Comment and Recommendations, 65553-65554 [2012-26498]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 209 / Monday, October 29, 2012 / Notices
other hand, occupational stress research
experts suggest that certain workplace
and other factors (e.g., co-worker and
supervisory support, anti-discrimination
policies and practices, etc.) may help
reduce stress among employees,
including racial and ethnic minorities.
The goals of this project are to
evaluate: (1) The degree of exposure of
minority and non-minority workers to
various workplace and job stressors (2)
the impact of these stressors on health
and safety outcomes and (3) the
organizational (e.g., organizational
characteristics, policies and practices)
and other factors that protect minority
and other workers from stress and
associated problems in health and
safety. The data collection will
ultimately help CDC/NIOSH focus
intervention and prevention efforts that
are designed to benefit the health and
safety of the diverse U.S. workforce.
The study entails collecting
standardized information from working
adults via a telephone interview.
Respondents will be asked about: (1)
Their exposure to workplace and job
stressors, including those related to race
and ethnicity (2) their health and safety
status and (3) organizational
characteristics, policies and practices
65553
that may or may not buffer them from
the adverse effects of work-related
stressors. Respondents will be a random
sample of 2,300 Blacks/African
Americans, White/European Americans,
Hispanic/Latino Americans, American
Indian/Alaska Natives, and Asian
Americans. All telephone interview
respondents will be between the ages of
18 and 65, English-speaking, either
currently employed or unemployed for
no more than 3 years, and living within
the Chicago Metropolitan area. There
are no costs to respondents other than
their time. The total estimated annual
burden hours are 1,150.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of
respondents
Number of
responses per
respondent
Average burden
per response
(in hrs)
Individual ...................................................
Telephone Interviews ...............................
2,300
1
30/60
Dated: October 23, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012–26496 Filed 10–26–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Project
Centers for Disease Control and
Prevention
[30Day–13–12MW]
rmajette on DSK2TPTVN1PROD with
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Kimberly S. Lane, at 1600
Clifton Road, MS D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
VerDate Mar<15>2010
13:18 Oct 26, 2012
Jkt 229001
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Hepatitis Testing and Linkage to Care
Monitoring & Evaluation System—NewNational Center for HIV/AIDS, Viral
Hepatitis, STD and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention is requesting a threeyear OMB approval for establishing a
Hepatitis Testing and Linkage to Care
(HEPTLC) Monitoring and Evaluation
System to collect standardized, nonidentifying, client-level and test-level
hepatitis testing information from
funded testing sites at multiple settings.
Grantees will be required to use this
web-based HEPTLC software
application to collect and report testing
and linkage to care activities.
The HEPTLC data collection and
reporting system will enable CDC to
receive standardized, non-identifying
information from funded grantees,
including: (1) Information about test
sites that provide HEPTLC services and
laboratories that provide lab testing; (2)
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
Information about testing participants,
including demographics, risk
characteristics, vaccination history, etc.
(3) Information related to diagnostic test
results; and (4)Information about posttest follow-ups, including notification of
test result, post-test-counseling, linkage
to care and preventive services, and case
report to surveillance authorities. CDC
will use HEPTLC data for the following
purposes: (1) Monitor the
implementation activities of the
HEPTLC initiative, as well as evaluate
the progress and performance made by
the grantees. Findings will further
inform strategic planning and program
improvement; (2) Inform
recommendations and strategies of
increasing early identification of
infected persons and linkage to care,
based on participant characteristics and
linkage to care among those persons
who are infected; (3) Identify best
practices and gaps in implementing
HEPTLC in various testing settings, and
guide CDC in providing technical
assistance to the grantees; (4) Produce
standardized and specialized reports
that will inform grantees, CDC Project
Officers, HHS, Congress and other
stakeholders of the process, outcome
and accountability measures; (5)Assess
public health prevention funds and
resources allocations with respect to
prioritized risk populations; (6)
Advocate the needs for priority setting
and budget allocation for hepatitis
prevention.
Funded sites will use HEPTLC data
for the following purposes: (1)
Understand targeted populations
(demographics, risk behaviors,
vaccination histories, etc) and assess the
E:\FR\FM\29OCN1.SGM
29OCN1
65554
Federal Register / Vol. 77, No. 209 / Monday, October 29, 2012 / Notices
extent to which the targeted populations
have been reached; (2) Document how
well the project is progressing in
meeting goals/objectives set forth by
CDC (e.g. who delivered what to whom,
how many, where, when, and how
well), as well as performance indicators
related to testing, counseling and
linkage to care; (3) Highlight
opportunities for local program
collaboration and service integration
(PCSI) to prevent hepatitis: (4)Fulfill
data collection and reporting
requirements outlined in the
cooperative agreements.
The data will enable CDC to be
accountable for the funding it provides,
the populations that are served, the
services being provided, and for the
strategies and practices effectiveness in
implementing HEPTLC. The data will
also enable CDC to be accountable to the
administration, Congress, or other
stakeholders for the proper use of public
money or provide transparency for the
programs it funds.
Respondents will be testing sites at
multiple settings, including health
departments, community based
organizations (CBOs), community health
centers (CHCs), person who inject drugs
(PWID) treatment centers, and other
settings, e.g. HIV or STD clinics,
Federally Qualified Health Centers
(FQHCs). They will routinely collect,
enter, and report information about the
test site, client demographics and
behaviors, testing results and linkage to
care follow up information within the
web-based HEPTLC system. CDC
anticipates that routine information
collection will begin once OMB
approval is received and will be carried
out through the project period
September 2012–September 2013.
There are no costs to respondents
other than their time. The total
estimated annual burden hours are
6000.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Responses
per
respondent
Type of respondents
Form name
HBV—CBOs/Health Jurisdictions ..................
HCV—multiple sites (IDU, CHCs, Others,
ECHO)
HBV—CBOs/Health Jurisdictions ..................
HCV—multiple sites (IDU, CHCs, Others,
ECHO)
HEPTLC Data Variables & Values (test-level
monthly reporting).
40
12
HEPTLC Template (program-level reporting/
quarterly).
40
4
Dated: October 22, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012–26498 Filed 10–26–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
rmajette on DSK2TPTVN1PROD with
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 8:30 a.m.–5:00 p.m.
Eastern Time, November 27, 2012.
Place: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky 41018.
Telephone (859) 334–4611, Fax (859) 334–
4619.
Status: Open to the public, but without an
oral public comment period. To access by
VerDate Mar<15>2010
13:18 Oct 26, 2012
Jkt 229001
conference call dial the following
information 1 (866) 659–0537, Participant
Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction, which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2013.
Purpose: The Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
12
1.5
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee for Dose
Reconstruction Reviews was established to
aid the Advisory Board in carrying out its
duty to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Discussed: The agenda for
the Subcommittee meeting includes:
Reconsidering the Board’s dose
reconstruction case review process; dose
reconstruction program quality management
and assurance activities, including: Current
findings from NIOSH internal dose
reconstruction blind reviews, presentation of
the test plan for validating dose
reconstruction tools, presentation of the
evolution of peer-review procedures,
presentation of statistics summarizing errors
detected and/or corrected through current
peer-review procedures; and discussion of
dose reconstruction cases under review (sets
8–9, Rocky Flats Plant cases from sets 10–13,
and two blind dose reconstruction cases).
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
Contact Person for More Information:
Theodore Katz, Executive Secretary, NIOSH,
CDC, 1600 Clifton Road, Mailstop E–20,
Atlanta, Georgia 30333. Telephone (513)
E:\FR\FM\29OCN1.SGM
29OCN1
]]>Agencies
[Federal Register Volume 77, Number 209 (Monday, October 29, 2012)]
[Notices]
[Pages 65553-65554]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-26498]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-13-12MW]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to Kimberly S. Lane, at 1600 Clifton Road, MS D74,
Atlanta, GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Hepatitis Testing and Linkage to Care Monitoring & Evaluation
System--New-National Center for HIV/AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for Disease Control and Prevention is
requesting a three-year OMB approval for establishing a Hepatitis
Testing and Linkage to Care (HEPTLC) Monitoring and Evaluation System
to collect standardized, non-identifying, client-level and test-level
hepatitis testing information from funded testing sites at multiple
settings. Grantees will be required to use this web-based HEPTLC
software application to collect and report testing and linkage to care
activities.
The HEPTLC data collection and reporting system will enable CDC to
receive standardized, non-identifying information from funded grantees,
including: (1) Information about test sites that provide HEPTLC
services and laboratories that provide lab testing; (2) Information
about testing participants, including demographics, risk
characteristics, vaccination history, etc. (3) Information related to
diagnostic test results; and (4)Information about post-test follow-ups,
including notification of test result, post-test-counseling, linkage to
care and preventive services, and case report to surveillance
authorities. CDC will use HEPTLC data for the following purposes: (1)
Monitor the implementation activities of the HEPTLC initiative, as well
as evaluate the progress and performance made by the grantees. Findings
will further inform strategic planning and program improvement; (2)
Inform recommendations and strategies of increasing early
identification of infected persons and linkage to care, based on
participant characteristics and linkage to care among those persons who
are infected; (3) Identify best practices and gaps in implementing
HEPTLC in various testing settings, and guide CDC in providing
technical assistance to the grantees; (4) Produce standardized and
specialized reports that will inform grantees, CDC Project Officers,
HHS, Congress and other stakeholders of the process, outcome and
accountability measures; (5)Assess public health prevention funds and
resources allocations with respect to prioritized risk populations; (6)
Advocate the needs for priority setting and budget allocation for
hepatitis prevention.
Funded sites will use HEPTLC data for the following purposes: (1)
Understand targeted populations (demographics, risk behaviors,
vaccination histories, etc) and assess the
[[Page 65554]]
extent to which the targeted populations have been reached; (2)
Document how well the project is progressing in meeting goals/
objectives set forth by CDC (e.g. who delivered what to whom, how many,
where, when, and how well), as well as performance indicators related
to testing, counseling and linkage to care; (3) Highlight opportunities
for local program collaboration and service integration (PCSI) to
prevent hepatitis: (4)Fulfill data collection and reporting
requirements outlined in the cooperative agreements.
The data will enable CDC to be accountable for the funding it
provides, the populations that are served, the services being provided,
and for the strategies and practices effectiveness in implementing
HEPTLC. The data will also enable CDC to be accountable to the
administration, Congress, or other stakeholders for the proper use of
public money or provide transparency for the programs it funds.
Respondents will be testing sites at multiple settings, including
health departments, community based organizations (CBOs), community
health centers (CHCs), person who inject drugs (PWID) treatment
centers, and other settings, e.g. HIV or STD clinics, Federally
Qualified Health Centers (FQHCs). They will routinely collect, enter,
and report information about the test site, client demographics and
behaviors, testing results and linkage to care follow up information
within the web-based HEPTLC system. CDC anticipates that routine
information collection will begin once OMB approval is received and
will be carried out through the project period September 2012-September
2013.
There are no costs to respondents other than their time. The total
estimated annual burden hours are 6000.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average burden
Type of respondents Form name Number of Responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
HBV--CBOs/Health Jurisdictions....... HEPTLC Data Variables & 40 12 12
HCV--multiple sites (IDU, CHCs, Values (test-level
Others, ECHO). monthly reporting).
HBV--CBOs/Health Jurisdictions....... HEPTLC Template (program- 40 4 1.5
HCV--multiple sites (IDU, CHCs, level reporting/
Others, ECHO). quarterly).
----------------------------------------------------------------------------------------------------------------
Dated: October 22, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI), Office of the Associate
Director for Science (OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012-26498 Filed 10-26-12; 8:45 am]
BILLING CODE 4163-18-P
